Back to Search
TIMOTHY HABERMANN, PHARMD
PHARMD
Pharmacist
NPI: 1407162910Individual
Specialties, Licenses & Credentials
Ambulatory Care Pharmacist
Pharmacist — Ambulatory Care
Code: 1835P2201X
117769(MN)
PharmacistPrimary
Pharmacist
Code: 183500000X
117769(MN)
Research & Publications (20)
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
PMID 19245430·Br J Haematol·2009
3-trial
Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
PMID 18288560·Clin Exp Nephrol·2008
5-case
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
PMID 18633131·Blood·2008
8-other
Antibody therapy in aggressive lymphomas.
PMID 18024638·Hematology Am Soc Hematol Educ Program·2007
6-review
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
PMID 16754935·J Clin Oncol·2006
3-trial
Splenectomy, interferon, and treatments of historical interest in hairy cell leukemia.
PMID 16990108·Hematol Oncol Clin North Am·2006
6-review
Images and reflections from Mayo Clinic Heritage. Henry S. Plummer.
PMID 12440554·Mayo Clin Proc·2002
8-other
Monoclonal antibody therapy for posttransplant lymphoproliferative disorders.
PMID 10980069·Liver Transpl·2000
5-case
Posttransplant lymphoproliferative disorder following pancreas transplantation.
PMID 19519812·Am J Transplant·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1407162910
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile